Development of rapid analysis of eye drops for monitoring during various technological operations

In this article, the composition and technology of combined eye drops were developed, including taurine as an anti-cataract agent and betaxolol hydrochloride as an anti-glaucoma agent. Butanol, toluene, isopropyl ether, chloroform, ammonia 25%, ethyl alcohol in various ratios were used as the mobile phase. However, these solutions and their combinations did not allow us to determine a system that makes it possible to register both active components simultaneously. Therefore, it was decided to select two thin layer chromatography systems, one of which made it possible to determine taurine, and the other betaxolol hydrochloride